Perspective Therapeutics (NYSEMKT: CATX)
$3.81
(-4.3%)
-$0.17
Price as of August 13, 2025, 4:00 p.m. ET
Perspective Therapeutics Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Perspective Therapeutics Company Info
Perspective Therapeutics, Inc. is a medical technology and radiopharmaceutical company, which engages in the provision of treatment applications for cancers. The company is headquartered in Richland, WA.
Valuation
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.